This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Alba Therapeutics (develops drugs and drug delivery adjuvants based on the zonulin pathway) raised $30mm in its Series A financing led by SV Life Sciences and Alta Partners. Other new investors HealthCap, Red Abbey Venture Partners, and the Maryland Venture Fund were joined by returning backers Esperance BioVentures, Astellas Ventures, Maryland TEDCO, and Townsend Capital.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?